Telesis Bio Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Telesis Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $566K, a 51% decline year-over-year.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.82M, a 39.3% decline year-over-year.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.96M, a 6.33% increase from 2022.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.73M, a 243% increase from 2021.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.09M, a 2426% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.96M +$236K +6.33% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $3.73M +$2.64M +243% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $1.09M +$1.04M +2426% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $43K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.